PROM1 and hepatocellular carcinoma: The cytoplasmic and nuclear levels of CD133 have been associated with poor prognosis in non-small cell lung cancer and hepatocellular carcinoma [13, 14, 17], but further investigation is needed to understand its role in these subcellular compartments.